Projects funded by the NCN
New 1,3,4-thiadiazole derivatives as inhibitors of critical steps of the glutamine-glutamate cycle in glioblastoma cells.
2013/11/D/NZ7/00925
Keywords:
1,3,4-thiadiazole derivatives glioblastoma glutamine glutamate glutaminase
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: SONATA 6 - announced on 2013-09-16
Amount awarded: 435 500 PLN
Project start date (Y-m-d): 2014-07-10
Project end date (Y-m-d): 2018-01-09
Project duration:: 42 months (the same as in the proposal)
Project status: Project settled